Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

October 2012; Volume 32,Issue 10
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Abatzoglou, IOANNIS

    1. You have access
      Postoperative Pelvic Hypofractionated Accelerated Radiotherapy with Cytoprotection (HypoARC) for High-risk or Recurrent Prostate Cancer
      MICHAEL I. KOUKOURAKIS, AIKATERINI PAPADOPOULOU, IOANNIS ABATZOGLOU, MARIANTHI PANTELIADOU, KYRIAKI SISMANIDOU and STAVROS TOULOUPIDIS
      Anticancer Research October 2012, 32 (10) 4561-4568;
  2. Abeilard-lemoisson, EDWIGE

    1. You have access
      siPGK1 Sensitizes Chemoresistant Human Ovarian Cancer Cell Lines to Cisplatin
      CHARLOTTE LEPLEUX, EDWIGE ABEILARD-LEMOISSON, MARYLINE DUVAL, PHILIPPE ICARD and HUBERT LINCET
      Anticancer Research October 2012, 32 (10) 4277-4286;
  3. Abrate, MARTINO

    1. You have access
      Haptoglobin Phenotype and Epithelial Ovarian Cancer
      VINCENZO DARIO MANDATO, ELENA MAGNANI, MARTINO ABRATE, BRUNO CASALI, DAVIDE NICOLI, ENRICO FARNETTI, DEBORA FORMISANO, DEBORA PIRILLO, GINO CIARLINI, PIERANDREA DE IACO, ISABELLA STRADA, CLAUDIO ZAMAGNI and GIOVANNI BATTISTA LA SALA
      Anticancer Research October 2012, 32 (10) 4353-4358;
  4. Aki, RYOICHI

    1. You have access
      Fluorescent Proteins Enhance UVC PDT of Cancer Cells
      MASASHI MOMIYAMA, ATSUSHI SUETSUGU, HIROAKI KIMURA, HIROYUKI KISHIMOTO, RYOICHI AKI, AKIMITSU YAMADA, HARUMI SAKURADA, TAKASHI CHISHIMA, MICHAEL BOUVET, NATALIA N. BULGAKOVA, ITARU ENDO and ROBERT M. HOFFMAN
      Anticancer Research October 2012, 32 (10) 4327-4330;
  5. Amtmann, EBERHARD

    1. You have access
      Glucocorticoids Augment Survival and Proliferation of Tumor Cells
      SIBYLLE GÜNDISCH, EVA BOECKELER, UTA BEHRENDS, EBERHARD AMTMANN, HARALD EHRHARDT and IRMELA JEREMIAS
      Anticancer Research October 2012, 32 (10) 4251-4261;
  6. Andersen, JEANETTE H.

    1. You have access
      Antitumoral and Mechanistic Studies of Ianthelline Isolated from the Arctic Sponge Stryphnus fortis
      KINE Ø. HANSSEN, JEANETTE H. ANDERSEN, TRINE STIBERG, RICHARD A. ENGH, JOHAN SVENSON, ANNE-MARIE GENEVIèRE and ESPEN HANSEN
      Anticancer Research October 2012, 32 (10) 4287-4297;
  7. Ando, MASAHIRO

    1. You have access
      Combination Chemotherapy of Alternating Etoposide and Carboplatin with Weekly Administration of Irinotecan and Cisplatin in Extensive-stage Small-cell Lung Cancer
      AKINOBU YOSHIMURA, RINTARO NORO, AKIHIKO MIYANAGA, HIDEAKI MIZUTANI, SEIJI KOSAIHIRA, YUJI MINEGISHI, MASAHIRO SEIKE, MITSUNORI HINO, MASAHIRO ANDO, KOICHIRO NOMURA, TETSUYA OKANO, KUNIHIKO KOBAYASHI, AKIHIKO GEMMA and THE EAST JAPAN CHESTERS GROUP
      Anticancer Research October 2012, 32 (10) 4473-4478;
  8. Antoniolli, STEFANO ZECCHININI

    1. You have access
      Investigative Clinical Study on Prostate Cancer Part IX and X: Estradiol and the Pituitary-Testicular-Prostate Axis at the Time of Initial Diagnosis and Subsequent Cluster Selection of the Patient Population after Radical Prostatectomy
      ANTONIO B. PORCARO, CLAUDIO GHIMENTON, ALDO PETROZZIELLO, TEODORO SAVA, FILIPPO MIGLIORINI, MARIO ROMANO, BEATRICE CARUSO, CLAUDIO COCCO, STEFANO ZECCHININI ANTONIOLLI, VINCENZO LACOLA, EMANUELE RUBILOTTA and CARMELO MONACO
      Anticancer Research October 2012, 32 (10) 4523-4532;
  9. Asciuto, THOMAS J.

    1. You have access
      Functional Profiling to Select Chemotherapy in Untreated, Advanced or Metastatic Non-small Cell Lung Cancer
      ROBERT A. NAGOURNEY, JONATHAN B. BLITZER, ROBERT L. SHUMAN, THOMAS J. ASCIUTO, EKNATH A. DEO, MARYLYN PAULSEN, ROBERT L. NEWCOMB and STEVE S. EVANS
      Anticancer Research October 2012, 32 (10) 4453-4460;
  10. Badal, SIMONE

    1. You have access
      Kinase Inhibition by the Jamaican Ball Moss, Tillandsia recurvata L.
      HENRY I.C. LOWE, CHARAH T. WATSON, SIMONE BADAL, NGEH J. TOYANG and JOSEPH BRYANT
      Anticancer Research October 2012, 32 (10) 4419-4422;
« Previous (Pages : 1 2 3 4 5 6 ... 38) Next »
Back to top
PreviousNext

In this issue

Anticancer Research: 32 (10)
Anticancer Research
Vol. 32, Issue 10
October 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire